Theravance Biopharma (NASDAQ:TBPH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Also check this: Tesla And 4 Other Stocks Sold By Insiders
Earnings
Theravance Biopharma beat estimated earnings by 45.45%, reporting an EPS of $-0.18 versus an estimate of $-0.33.
Revenue was up $3.79 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 5.2% increase in the share price the next day.
Here's a look at Theravance Biopharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.55 | -1.01 | -1.05 | -1.02 |
| EPS Actual | -0.46 | -0.80 | -1.24 | -0.92 |
| Revenue Estimate | 14.69M | 15.41M | 17.27M | 20.85M |
| Revenue Actual | 13.19M | 12.91M | 14.26M | 18.73M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
